Advanced search
Publication Cover
International Reviews of Immunology Volume 20, 2001 - Issue 3-4
Submit an article Journal homepage
58
Views
27
CrossRef citations to date
0
Altmetric
Original Article

Ontogeny and Expansion of Human Natural Killer Cells: Clinical Implications

Todd A. Fehniger Department of Internal Medicine, Division of Hematology/Oncology, Department of Molecular Virology, Immunology and Medical Genetics, Division of Human Cancer Genetics; and the Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA
&
Michael A. Caligiuri Department of Internal Medicine, Division of Hematology/Oncology, Department of Molecular Virology, Immunology and Medical Genetics, Division of Human Cancer Genetics; and the Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USACorrespondence[email protected]
Pages 503-536 | Published online: 10 Jul 2009

Citations (27)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Surojit Karmakar, Pradipta Pal & Girdhari Lal. (2021) Key Activating and Inhibitory Ligands Involved in the Mobilization of Natural Killer Cells for Cancer Immunotherapies. ImmunoTargets and Therapy 10, pages 387-407.
Read now
Jesus I. Luna, Steven K. Grossenbacher, William J. Murphy & Robert J. Canter. (2017) Targeting Cancer Stem Cells with Natural Killer Cell Immunotherapy. Expert Opinion on Biological Therapy 17:3, pages 313-324.
Read now
Frances T Hakim & Ronald E Gress. (2005) Immunosenescence: immune deficits in the elderly and therapeutic strategies to enhance immune competence. Expert Review of Clinical Immunology 1:3, pages 443-458.
Read now

Articles from other publishers (24)

Surojit Karmakar, Amrita Mishra, Pradipta Pal & Girdhari Lal. (2023) Effector and cytolytic function of natural killer cells in anticancer immunity. Journal of Leukocyte Biology.
Crossref
Mihnea T. Zdrenghea. (2013) Could interleukin-15 potentiate histone deacetylase inhibitor effects in haematological malignancy?. Medical Hypotheses 81:2, pages 311-315.
Crossref
Noriko Shimasaki & Dario Campana. 2013. Synthetic Messenger RNA and Cell Metabolism Modulation. Synthetic Messenger RNA and Cell Metabolism Modulation 203 220 .
Melissa A Geller & Jeffrey S Miller. (2011) Use of allogeneic NK cells for cancer immunotherapy. Immunotherapy 3:12, pages 1445-1459.
Crossref
Gopalan Soman, Xiaoyi Yang, Hengguang Jiang, Steve Giardina, Vinay Vyas, George Mitra, Jason Yovandich, Stephen P. Creekmore, Thomas A. Waldmann, Octavio Quiñones & W. Gregory Alvord. (2009) MTS dye based colorimetric CTLL-2 cell proliferation assay for product release and stability monitoring of Interleukin-15: Assay qualification, standardization and statistical analysis. Journal of Immunological Methods 348:1-2, pages 83-94.
Crossref
Duck ChoDario Campana. (2009) Expansion and Activation of Natural Killer Cells for Cancer Immunotherapy. The Korean Journal of Laboratory Medicine 29:2, pages 89.
Crossref
Evren Alici, Tolga Sutlu & M. Sirac Dilber. 2009. Genetic Modification of Hematopoietic Stem Cells. Genetic Modification of Hematopoietic Stem Cells 127 137 .
Eckard Hamelmann, Udo Herz, Pat Holt, Arne Host, Roger P. Lauener, Paolo M. Matricardi, Ulrich Wahn & Magnus Wickman. (2008) New visions for basic research and primary prevention of pediatric allergy: An iPAC summary and future trends. Pediatric Allergy and Immunology 19, pages 4-16.
Crossref
H. P. Carroll, V. Paunovic & M. Gadina. (2008) Signalling, inflammation and arthritis: Crossed signals: the role of interleukin-15 and -18 in autoimmunity. Rheumatology 47:9, pages 1269-1277.
Crossref
Nelson Fausto. (2006) Involvement of the innate immune system in liver regeneration and injury. Journal of Hepatology 45:3, pages 347-349.
Crossref
Sherif S. Farag & Michael A. Caligiuri. (2006) Human natural killer cell development and biology. Blood Reviews 20:3, pages 123-137.
Crossref
Hayrettin Guven, Kyriakos V. Konstantinidis, Evren Alici, Alar Aints, Manuchehr Abedi-Valugerdi, Birger Christensson, Hans-Gustaf Ljunggren & M. Sirac Dilber. (2005) Efficient gene transfer into primary human natural killer cells by retroviral transduction. Experimental Hematology 33:11, pages 1320-1328.
Crossref
Chihaya ImaiShotaro IwamotoDario Campana. (2005) Genetic modification of primary natural killer cells overcomes inhibitory signals and induces specific killing of leukemic cells. Blood 106:1, pages 376-383.
Crossref
Jean-Hugues Dalle, Jos? Menezes, ?ric Wagner, Marie Blagdon, Josette Champagne, Martin A Champagne & Michel Duval. (2005) Characterization of Cord Blood Natural Killer Cells: Implications for Transplantation and Neonatal Infections. Pediatric Research 57:5 Part 1, pages 649-655.
Crossref
Brian Becknell, Rossana Trotta, Jianhua Yu, Wei Ding, Hsiaoyin C. Mao, Tiffany Hughes, Trent Marburger & Michael A. Caligiuri. (2005) Efficient infection of human natural killer cells with an EBV/retroviral hybrid vector. Journal of Immunological Methods 296:1-2, pages 115-123.
Crossref
Jana Barlic, David H. McDermott, Maya N. Merrell, Jacqueline Gonzales, Laura E. Via & Philip M. Murphy. (2004) Interleukin (IL)-15 and IL-2 Reciprocally Regulate Expression of the Chemokine Receptor CX3CR1 through Selective NFAT1- and NFAT2-dependent Mechanisms. Journal of Biological Chemistry 279:47, pages 48520-48534.
Crossref
Julian J. Lum, David J. Schnepple, Zilin Nie, Jaime Sanchez-Dardon, Georgina L. Mbisa, Jennifer Mihowich, Nanci Hawley, Shanil Narayan, John E. Kim, David H. Lynch & Andrew D. Badley. (2004) Differential Effects of Interleukin-7 and Interleukin-15 on NK Cell Anti-Human Immunodeficiency Virus Activity. Journal of Virology 78:11, pages 6033-6042.
Crossref
Sherif S. Farag & Michael A. Caligiuri. 2004. Treatment of Leukemia and Lymphoma. Treatment of Leukemia and Lymphoma 295 318 .
Keith E. Langley. 2004. Hematopoietic Growth Factors in Oncology. Hematopoietic Growth Factors in Oncology 153 184 .
Daila S. GridleyGregory A. Nelson, Luanne L. Peters, Paul J. Kostenuik, Ted A. BatemanSean Morony, Louis S. StodieckDavid L. Lacey, Steven J. SimskeMichael J. Pecaut. (2003) Selected Contribution: Effects of spaceflight on immunity in the C57BL/6 mouse. II. Activation, cytokines, erythrocytes, and platelets. Journal of Applied Physiology 94:5, pages 2095-2103.
Crossref
Sherif S. Farag, Jeffrey B. VanDeusen, Todd A. Fehniger & Michael A. Caligiuri. (2003) Biology and clinical impact of human natural killer cells. International Journal of Hematology 78:1, pages 7-17.
Crossref
Francesco Colucci, James P. Di Santo & Paul J. Leibson. (2002) Natural killer cell activation in mice and men: different triggers for similar weapons?. Nature Immunology 3:9, pages 807-813.
Crossref
Mary C. Nakamura, MD. (2002) Natural Killer Cells and Their Role in Disease. Laboratory Medicine 33:4, pages 278-282.
Crossref
Megan A Cooper, Todd A Fehniger & Michael A Caligiuri. (2001) The biology of human natural killer-cell subsets. Trends in Immunology 22:11, pages 633-640.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.